MEF2A Protein
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">MEF2A Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Myocyte Enhancer Factor 2A</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>MEF2A</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q02078</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>4205</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>507 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~55 kDa</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>MEF2 transcription factors</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Nucleus</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">Small molecule activators</td>
<td>Enhance MEF2A activity</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-MEF2A delivery</td>
</tr>
<tr>
<td class="label">Epigenetic modulators</td>
<td>[HDAC](/entities/hdac-enzymes) inhibitors</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/cardiovascular" style="color:#ef9a9a">Cardiovascular</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/senescence" style="color:#ef9a9a">Senescence</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">29 edges</a></td>
</tr>
</table>
Mef2A Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
MEF2A (Myocyte Enhancer Factor 2A) is a 507-amino acid transcription factor belonging to the MADS box family. It functions as an activity-dependent regulator of gene expression essential for neuronal development, synaptic plasticity, and cognitive function.
Overview
Myocyte Enhancer Factor 2A (MEF2A) is a transcription factor belonging to the MADS box family of DNA-binding proteins. MEF2A plays critical roles in neuronal development, synaptic plasticity, memory formation, and cognitive function. Dysregulation of MEF2A has been implicated in various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.
This page provides comprehensive information on MEF2A protein structure, function, disease associations, and therapeutic targeting approaches.
Protein Overview
Protein Structure
MEF2A contains conserved functional domains:
MADS Domain (N-terminal)
- DNA-binding motif (56 aa)
- Dimerization interface
- Co-factor recruitment
- Binds A/T-rich DNA sequences
MEF2 Domain
- Specific to MEF2 family
- Mediates dimerization
- Interacts with co-repressors
- Contains transcriptional activation domain
Transactivation Domain (C-terminal)
- Interaction with coactivators
- Histone acetyltransferase recruitment
- Chromatin remodeling complexes
Regulatory Regions
- Multiple phosphorylation sites
- Calcineurin-responsive elements
- MAPK target sites
Molecular Function
DNA Binding
MEF2A binds to MEF2 response elements:
- Consensus: C/TAAGATAAGAAT (canonical)
- Usually located in enhancers/promoters
- Multiple binding sites per target gene
Transcriptional Regulation
MEF2A controls diverse gene programs:
- Synaptic proteins (Synapsin, Synaptophysin)
- Calcium signaling components (CaMKII, Calmodulin)
- Cytoskeletal proteins (Actin, Tubulin)
- Neuronal survival factors (BDNF)
Activity-Dependent Regulation
MEF2A responds to neuronal activity:
- Calcium influx activates calcineurin
- Dephosphorylation enhances activity
- MAPK pathways modulate function
- Integrates multiple signaling inputs
Synaptic Plasticity
MEF2A regulates:
- AMPA receptor subunit expression
- [NMDA](/entities/nmda-receptor) receptor signaling
- [Long-term potentiation](/mechanisms/long-term-potentiation) (LTP)
- Long-term depression (LTD)
Expression Pattern
MEF2A is widely expressed in the brain:
- Cerebral [cortex](/brain-regions/cortex): High in pyramidal [neurons](/entities/neurons) (layers 2-6)
- [Hippocampus](/brain-regions/hippocampus): CA1-CA3 pyramidal cells, dentate gyrus
- Cerebellum: Purkinje cells
- Basal ganglia: Striatal medium spiny neurons
- Brainstem: Various nuclei
Expression is maintained in adult brain, supporting ongoing synaptic plasticity.
Role in Disease
Alzheimer's Disease
MEF2A involvement in AD:
- Reduced expression in AD brain<sup>[1]</sup>
- Controls synaptic protein genes
- Potential neuroprotective function
- Therapeutic target
Parkinson's Disease
- Regulates dopaminergic neuron genes
- May protect against [α-synuclein](/proteins/alpha-synuclein) toxicity
- Altered expression in PD models
Stroke
MEF2A provides neuroprotection:
- Ischemic preconditioning activates MEF2A
- Regulates survival genes
- Potential therapeutic target
Psychiatric Disorders
- Schizophrenia: Altered expression in prefrontal cortex
- Depression: May regulate mood-related genes
- Autism: Synaptic dysfunction
Therapeutic Targeting
Background
The study of Mef2A Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
<sup>[1]</sup> Flavell SW, et al. (2006). "MEF2A regulates activity-dependent gene programs in neurons." Neuron. 52(1): 103-120.
<sup>[2]</sup> Pulipparacharuvil S, et al. (2008). "Cocaine regulates MEF2 to control synaptic plasticity." Neuron. 59(4): 621-633.
<sup>[3]</sup> Li H, et al. (2011). "MEF2A protects neurons against ischemic injury." Journal of Cerebral Blood Flow & Metabolism. 31(3): 779-789.
<sup>[4]</sup> Barbosa AC, et al. (2008). "MEF2A, a transcription factor important for neuronal survival." Cell Death & Differentiation. 15(10): 1592-1603.
<sup>[5]</sup> Zhou C, et al. (2019). "MEF2A and neurodegenerative diseases." Frontiers in Molecular Neuroscience. 12: 142.
See Also
- [MEF2A Gene](/genes/mef2a)
- [Transcription Factors](/mechanisms/transcription-regulation-neurodegeneration)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
External Links
- [MEF2A Protein - UniProt](https://www.uniprot.org/uniprot/Q02078)
- [MEF2A Gene - NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/4205)